Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.

OBJECTIVES: There are few data on the cost-effectiveness of bisphosphonates with oral glucocorticoids (GCs). An individual patient-based pharmaco-economic model was developed. METHODS: Data were obtained from a cohort of oral GC users aged 40+ (n = 190 000) in the UK General Practice Research Databa...

Full description

Bibliographic Details
Main Authors: van Staa, T, Geusens, P, Zhang, B, Leufkens, H, Boonen, A, Cooper, C
Format: Journal article
Language:English
Published: 2007